Since its inception in 1920, The Union has had a focus on tuberculosis (TB) and innovating TB care.
We have now set out our 2022-2027 vision, objectives and strategy for ending TB. This can only be achieved collectively, with our members, partners and TB community – everyone has a role to play.
Together, we can bring an end to TB.
Our work in TB
The Union works towards the global elimination of TB. We support high-quality, accessible prevention and care for people with and at risk of TB, to expand the evidence base for TB care and prevention and implement new knowledge into policy and practice.
Project Axshya
In collaboration with local partners and over 15,000 community volunteers, The Union provided innovative tuberculosis (TB) interventions designed to serve traditionally hard-to-reach and at-risk populations in India.
Specific TB priority areas
Read more about how The Union is working to fight key areas of TB:
Child & Adolescent Tuberculosis
The Union works to develop, test, implement and scale up routine screening of child contacts of people with TB. We run observational studies and advocate to ensure children and adolescents are included in clinical trials that target diagnostics, vaccines and treatment of TB disease and infection.
TB-HIV, TB-Diabetes and other co-morbidities
The Union develops, tests, implements and scales up models of care for co-morbid conditions that increase the risk of developing TB, that are prevalent in high TB burden settings, or that adversely affect TB treatment outcomes.
The Zoonotic TB Sub-section was instrumental in the creation of the first-ever Roadmap for Zoonotic TB, a policy document that addressed the major health and economic impacts of the disease, created in collaboration with the World Health Organization.
Members work together to influence global policy and practice, ensuring their work has a greater global impact.
Understand the issues with our factsheets
Tuberculosis Union news
Union response to latest edition of the G-Finder report on R&D for neglected diseases
Policy Cures Research has released the 2018 G-Finder report analysing research and development funding trends for 33 neglected diseases…
New Union technical guide for the co-management of diabetes mellitus-tuberculosis published
The guide, developed in partnership with the World Diabetes Foundation, provides essential information for frontline health…
TREATS and King’s College London collaboration awarded funding to develop a new TB diagnostic
Tuberculosis (TB) is the world’s leading infectious disease killer, with 10 million people falling ill with active TB disease every year…
Georgia Community Advisory Board: Supporting STREAM Trial participants for successful treatment outcomes
At a recent meeting of the STREAM Community Advisory Board (CAB), Georgia, held in Tbilisi at the National Center for Tuberculosis and…
A new era for global tuberculosis: holding leaders accountable for promises
Read the editorial from The Union leadership, highlighting the next steps for leaders in tuberculosis, which was published in The…
Union response to WHO updated treatment guidelines for multidrug- and rifampicin-resistant tuberculosis
In response to the publication of new guidelines from the World Health Organization (WHO) on the treatment of multidrug-resistant…
TB Publications
Until recently, the focus has been on finding and treating people with TB. But now bold targets for TB prevention have been outlined in the recent UN High-Level Meeting on TB. The Union develops, tests, implements and scales up models of care to increase the uptake and completion of TB preventive treatments in key high risk groups including children under 5 and people living with HIV.
'Prevent Tuberculosis: Management of TB Infection' is a free course which improves knowledge of all aspects of the management of TB infection including the diagnosis and treatment of tuberculosis with the specific aim of increasing country-level implementation of TB prevention among i) household contact of people affected by TB, especially those under five years of age, ii) persons with risk factors to develop TB, and iii) people living with HIV in care.